WHEN DO WE HAVE to PERFORM CARDIAC MAGNETIC RESONANCE in PATIENTS REFERRED for PREMATURE VENTRICULAR COMPLEXES by THEIR CARDIOLOGISTS

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Jan 24, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at when cardiac magnetic resonance (CMR) imaging should be used for patients who have premature ventricular complexes (PVCs). PVCs are extra heartbeats that most people experience at some point and can cause symptoms like palpitations or chest pain. While some tests like ECGs and echocardiograms are often done first to check for heart problems, they might not always find underlying issues. CMR is a more advanced imaging technique that can help identify heart conditions that other tests may miss. The trial aims to understand how and when CMR can provide additional information to help doctors make better diagnoses for patients with PVCs.

To be eligible for this trial, participants need to have had PVCs and have already completed an ECG, Holter monitor test (a type of heart rhythm test), and a CMR scan. The study is open to all adults aged 65 to 74. Participants can expect to contribute to important research that will help clarify the role of CMR in managing PVCs, potentially benefiting future patients. Additionally, anyone who doesn’t want their personal data used for research or has language difficulties in French may not be included in the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with PVC who have performed ECG, Holter ECG and a CMR
• Exclusion Criteria:
• • patient showing opposition tu use his personal data for the reseach,
• • patient unable to express his opposition,
• • patient deprived of liberty,
• • patient with language issues (speaking or writing French)